These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 19262497

  • 1. Urinary prostasin in humans: relationships among prostasin, aldosterone and epithelial sodium channel activity.
    Koda A, Wakida N, Toriyama K, Yamamoto K, Iijima H, Tomita K, Kitamura K.
    Hypertens Res; 2009 Apr; 32(4):276-81. PubMed ID: 19262497
    [Abstract] [Full Text] [Related]

  • 2. Regulation of prostasin by aldosterone in the kidney.
    Narikiyo T, Kitamura K, Adachi M, Miyoshi T, Iwashita K, Shiraishi N, Nonoguchi H, Chen LM, Chai KX, Chao J, Tomita K.
    J Clin Invest; 2002 Feb; 109(3):401-8. PubMed ID: 11828000
    [Abstract] [Full Text] [Related]

  • 3. Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium.
    Olivieri O, Chiecchi L, Pizzolo F, Castagna A, Raffaelli R, Gunasekaran M, Guarini P, Consoli L, Salvagno G, Kitamura K.
    Hypertens Res; 2013 Jun; 36(6):528-33. PubMed ID: 23344129
    [Abstract] [Full Text] [Related]

  • 4. In vivo induction of prostasin mRNA in colonic epithelial cells by dietary sodium depletion and aldosterone infusion in rats.
    Fukushima K, Naito H, Funayama Y, Yonezawa H, Haneda S, Shibata C, Sasaki I.
    J Gastroenterol; 2004 Oct; 39(10):940-7. PubMed ID: 15549446
    [Abstract] [Full Text] [Related]

  • 5. Urinary prostasin: a candidate marker of epithelial sodium channel activation in humans.
    Olivieri O, Castagna A, Guarini P, Chiecchi L, Sabaini G, Pizzolo F, Corrocher R, Righetti PG.
    Hypertension; 2005 Oct; 46(4):683-8. PubMed ID: 16172430
    [Abstract] [Full Text] [Related]

  • 6. Biochemical characterization of prostasin, a channel activating protease.
    Shipway A, Danahay H, Williams JA, Tully DC, Backes BJ, Harris JL.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):953-63. PubMed ID: 15474520
    [Abstract] [Full Text] [Related]

  • 7. Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism.
    Pizzolo F, Chiecchi L, Morandini F, Castagna A, Zorzi F, Zaltron C, Pattini P, Chiariello C, Salvagno G, Olivieri O.
    J Hypertens; 2017 Feb 12; 35(2):355-361. PubMed ID: 27841781
    [Abstract] [Full Text] [Related]

  • 8. Dietary Na+ intake in healthy humans changes the urine extracellular vesicle prostasin abundance while the vesicle excretion rate, NCC, and ENaC are not altered.
    Zachar R, Jensen BL, Svenningsen P.
    Am J Physiol Renal Physiol; 2019 Dec 01; 317(6):F1612-F1622. PubMed ID: 31566425
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Albuminuria is associated with an increased prostasin in urine while aldosterone has no direct effect on urine and kidney tissue abundance of prostasin.
    Oxlund C, Kurt B, Schwarzensteiner I, Hansen MR, Stæhr M, Svenningsen P, Jacobsen IA, Hansen PB, Thuesen AD, Toft A, Hinrichs GR, Bistrup C, Jensen BL.
    Pflugers Arch; 2017 Jun 01; 469(5-6):655-667. PubMed ID: 28233126
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-beta1 and aldosterone.
    Wakida N, Kitamura K, Tuyen DG, Maekawa A, Miyoshi T, Adachi M, Shiraishi N, Ko T, Ha V, Nonoguchi H, Tomita K.
    Kidney Int; 2006 Oct 01; 70(8):1432-8. PubMed ID: 16941024
    [Abstract] [Full Text] [Related]

  • 13. A polymorphic GT short tandem repeat affecting beta-ENaC mRNA expression is associated with low renin essential hypertension.
    González AA, Carvajal CA, Riquelme E, Krall PM, Munoz CR, Mosso LM, Kalergis AM, Fardella CE.
    Am J Hypertens; 2007 Jul 01; 20(7):800-6. PubMed ID: 17586416
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urinary prostasin excretion is associated with adiposity in nonhypertensive African-American adolescents.
    Guo DH, Parikh SJ, Chao J, Pollock NK, Wang X, Snieder H, Navis G, Wilson JG, Bhagatwala J, Zhu H, Dong Y.
    Pediatr Res; 2013 Aug 01; 74(2):206-10. PubMed ID: 23863785
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension.
    Maekawa A, Kakizoe Y, Miyoshi T, Wakida N, Ko T, Shiraishi N, Adachi M, Tomita K, Kitamura K.
    J Hypertens; 2009 Jan 01; 27(1):181-9. PubMed ID: 19145783
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Circadian exosomal expression of renal thiazide-sensitive NaCl cotransporter (NCC) and prostasin in healthy individuals.
    Castagna A, Pizzolo F, Chiecchi L, Morandini F, Channavajjhala SK, Guarini P, Salvagno G, Olivieri O.
    Proteomics Clin Appl; 2015 Jun 01; 9(5-6):623-9. PubMed ID: 25931204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.